Early epstein–barr virus–driven immune dysregulation after cardiac transplantation in trisomy 21 resulting in post-transplant lymphoproliferative disorder and haemophagocytic lymphohistiocytosis

31 August 2026 (08:30 - 08:45)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Mohammed Aljaafari

Western University, London (Canada)

3 More presentations in this session

Presentation thumbnail

Rare presentation of asymptomatic left ventricular pseudoaneurysm in a patient with well-controlled HIV infection

Doctor H. Septar (Bucharest, RO)

Presentation thumbnail

Multimodality imaging of intracardiac thrombosis and pulmonary artery aneurysms revealing vascular Behcet disease: a cautionary tale against premature anticoagulation

Doctor A. Idrissi Tlemcani (Tangier, MA)

Presentation thumbnail

Complete atrioventricular block as the presenting manifestation of Takayasu arteritis in a young adult

Doctor H. Kalkoul (Algiers, DZ)

Access the full session

Session thumbnail

When the heart reveals systemic disease

The Event

Event poster

ESC Congress 2026

31 August 2026 08:30 CET

You may be interested in

Congress Session

Challenging cases in heart transplantation

11 May 2026

Congress Presentation

Myocarditis related heart failure from hemophagocytic lymphohistiocytosis secondary to newly diagnosed classic hodgkins lymphoma

12 May 2026

Congress Presentation

The Heart of the Matter- Late cardiotoxicity with severe biventricular dysfunction in a young patient with non-Hodgkin Lymphoma treated with R-CHOP

1 September 2024

Congress Presentation

Steroid-refractory fulminant lymphocytic myocarditis successfully treated with tacrolimus guided by serial cardiovascular magnetic resonance

28 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources